Equity Capital Markets

Company · CIK 1882782

Odyssey Therapeutics, Inc.

CIK1882782 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedODTX (Nasdaq)
First annual or quarterly report2026-06-17

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-295141
IPOFinal prospectus
 2026-04-172026-05-084
333-284332
First-time registrationWithdrawn
 2025-01-172025-06-092

Filings

8
FiledFilingRegistrationAccession
2026-05-08424B4Final prospectus 333-2951410001193125-26-214819
2026-05-07EFFECTDeclared effective 333-2951419999999995-26-001538
2026-05-04S-1/AAmendment 333-2951410001193125-26-202398
2026-04-17S-1Registration filed 333-2951410001193125-26-161514
2026-02-06DRSDraft made public 377-090190001193125-26-041396
2025-06-09RWWithdrawn 333-2843320001193125-25-137861
2025-01-17S-1Registration filed 333-2843320001193125-25-008362
2024-10-07DRSDraft made public 377-074860000950123-24-009534

All filings of this company · CSV